March 4, 2025

Ron Finklestien

Lead the Charge: Join MRVI Investors in a Securities Fraud Lawsuit Against Maravai LifeSciences Holdings, Inc. with Schall Law Firm

Class Action Lawsuit Filed Against Maravai LifeSciences Holdings

The Schall Law Firm, a national shareholder rights litigation firm, announces a class action lawsuit against Maravai LifeSciences Holdings, Inc. (“Maravai” or “the Company”) MRVI. The lawsuit addresses violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 along with Rule 10b-5 issued by the U.S. Securities and Exchange Commission.

Investors who acquired the Company’s securities between August 7, 2024, and February 24, 2025 (the “Class Period”), should reach out to the firm before May 5, 2025.

Shareholders who experienced financial losses are invited to participate in the lawsuit by clicking here.

For a free consultation about your rights, please contact Brian Schall of the Schall Law Firm at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, or call 310-301-3335. You may also reach us via the firm’s website at www.schallfirm.com or email [email protected].

Currently, the class has not been certified. As such, until the certification occurs, investors are not represented by an attorney. Those who decide to take no action will remain absent class members.

According to the Complaint, Maravai issued false and misleading statements to the market. It allegedly failed to uphold adequate internal controls over financial reporting and improperly recognized revenue from specific transactions during fiscal 2024. Additionally, the Company is accused of overstating its goodwill. Due to these inaccuracies, Maravai’s public disclosures were deemed false and materially misleading throughout the Class Period. As a result, investors incurred losses when the real facts emerged.

Join the lawsuit to seek recovery of your losses.

The Schall Law Firm advocates for investors worldwide and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be classified as Attorney Advertising in certain jurisdictions under relevant laws and ethical standards.

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

Market News and Data brought to you by Benzinga APIs


Subscribe to Pivot and Flow Daily